Profile data is unavailable for this security.
About the company
BrightGene Bio-Medical Technology Co Ltd is a China-based company mainly engaged in the research, development and production of generic drugs and original new drugs. The Company's main products include antifungal active pharmaceutical ingredients (APIs), antiviral APIs, immunosuppressive APIs, and other APIs and preparations. The Company's generic drugs mainly include entecavir, caspofungin, micafungin, posaconazole, everolimus and fondaparinux sodium. The Company mainly conducts its businesses in domestic and overseas markets.
- Revenue in CNY (TTM)1.21bn
- Net income in CNY195.77m
- Incorporated2001
- Employees1.16k
- LocationBrightGene Bio-Medical Technology Co LtdBuilding C25-28, No.218 Xinghu Road, SipSUZHOU 215123ChinaCHN
- Phone+86 51 262620988
- Fax+86 51 262551799
- Websitehttps://www.bright-gene.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Henan Lingrui Pharmaceutical Co., Ltd. | 3.43bn | 614.24m | 13.73bn | 2.53k | 22.21 | 4.65 | -- | 4.00 | 1.09 | 1.09 | 6.09 | 5.21 | 0.7246 | 2.04 | 13.84 | 1,356,471.00 | 12.97 | 10.68 | 21.27 | 16.56 | 71.74 | 74.42 | 17.90 | 14.92 | 1.26 | -- | 0.0122 | 72.80 | 10.31 | 10.03 | 22.09 | 18.49 | -16.47 | 39.77 |
| Mabwell Shanghai Bioscience Co Ltd | 191.35m | -1.02bn | 13.79bn | 1.49k | -- | 5.73 | -- | 72.05 | -2.55 | -2.55 | 0.4789 | 6.02 | 0.0412 | 0.0472 | 16.79 | 128,337.60 | -22.02 | -37.61 | -26.37 | -45.95 | 96.84 | 81.54 | -534.78 | -2,112.26 | 1.96 | -- | 0.442 | -- | 361.03 | 27.88 | -10.28 | -- | 17.35 | -- |
| Sunshine Guojian Pharmcutcl Shngh Co Ltd | 1.07bn | 352.22m | 13.89bn | 965.00 | 39.44 | 2.78 | -- | 12.94 | 0.571 | 0.571 | 1.74 | 8.09 | 0.2078 | 1.14 | 9.25 | 1,112,527.00 | 6.61 | 1.32 | 6.93 | 1.41 | 77.85 | 80.74 | 31.81 | 6.55 | 6.66 | -- | 0.01 | 8.25 | 22.84 | -2.35 | 497.63 | -4.44 | 21.22 | -- |
| Changchun BCHT Biotechnology Co | 1.92bn | 543.19m | 14.06bn | 1.24k | 25.84 | 3.44 | -- | 7.34 | 1.32 | 1.32 | 4.64 | 9.88 | 0.4116 | 0.8459 | 1.55 | 1,543,550.00 | 11.67 | 9.95 | 14.14 | 12.81 | 89.90 | 86.63 | 28.36 | 24.03 | 2.03 | -- | 0.0158 | 10.55 | 70.30 | 12.36 | 175.98 | 31.37 | 21.04 | -- |
| Suzhou Zelgen Biopharmaceuticals Co Ltd | 386.57m | -260.85m | 14.73bn | 867.00 | -- | 9.24 | -- | 38.10 | -1.00 | -1.00 | 1.49 | 6.02 | 0.1621 | 0.2594 | 3.75 | 445,874.00 | -11.74 | -27.13 | -20.82 | -39.20 | 92.29 | 92.75 | -72.40 | -220.71 | 2.15 | -- | 0.3842 | -- | 27.83 | 211.81 | 39.08 | -- | 41.38 | -- |
| Anhui Huaheng Biotechnology Co Ltd | 2.04bn | 454.44m | 14.93bn | 1.69k | 32.92 | 7.80 | -- | 7.32 | 2.88 | 2.88 | 12.92 | 12.15 | 0.6196 | 5.59 | 8.04 | 1,205,674.00 | 13.71 | 16.74 | 21.59 | 22.41 | 38.49 | 39.21 | 22.13 | 22.34 | 0.4552 | 155.98 | 0.4552 | 25.20 | 36.63 | 35.72 | 40.32 | 42.84 | 82.09 | -- |
| BrightGene Bio-Medical Technology Co Ltd | 1.21bn | 195.77m | 15.01bn | 1.16k | 77.76 | 6.18 | -- | 12.36 | 0.4569 | 0.4569 | 2.87 | 5.75 | 0.2463 | 1.69 | 4.43 | 1,051,700.00 | 3.43 | 6.53 | 4.29 | 7.93 | 54.92 | 56.93 | 13.93 | 19.90 | 1.45 | 4.86 | 0.4787 | 29.31 | 15.94 | 23.68 | -15.51 | 22.56 | 29.13 | -- |
| Liaoning Cheng Da Co Ltd | 11.18bn | 17.48m | 15.11bn | 3.36k | 760.00 | 0.5182 | -- | 1.35 | 0.013 | 0.013 | 7.34 | 19.07 | 0.2358 | 4.41 | 6.49 | 3,330,121.00 | -0.5366 | 3.59 | -0.7644 | 5.21 | 16.03 | 14.15 | -2.28 | 9.89 | 0.7792 | -- | 0.2834 | 15.93 | -25.97 | -10.97 | -80.95 | -21.26 | 7.04 | -- |
| KPC Pharmaceuticals Inc | 7.65bn | 432.35m | 15.27bn | 5.05k | 35.04 | 2.82 | -- | 2.00 | 0.5757 | 0.5757 | 10.20 | 7.15 | 0.8021 | 2.48 | 2.62 | 1,513,702.00 | 4.63 | 5.42 | 7.76 | 9.13 | 43.12 | 43.68 | 5.77 | 5.70 | 1.46 | 53.93 | 0.1688 | 35.75 | -6.99 | 1.64 | 16.05 | 5.79 | -21.33 | 14.87 |
| Shanghai Shyndec Pharmaceutical Co Ltd | 11.78bn | 843.91m | 15.33bn | 11.61k | 17.88 | 1.21 | -- | 1.30 | 0.6394 | 0.6394 | 8.95 | 9.48 | 0.6069 | 3.08 | 6.61 | 1,014,487.00 | 5.75 | 4.85 | 8.50 | 8.17 | 37.09 | 43.00 | 9.48 | 7.03 | 1.82 | -- | 0.1057 | 17.52 | -6.86 | 1.29 | 10.21 | -0.3897 | -2.21 | 0.00 |
| Dizal Jiangsu Pharmaceutical Co Ltd | 172.61m | -1.09bn | 16.40bn | 581.00 | -- | 23.54 | -- | 95.00 | -2.67 | -2.67 | 0.422 | 1.68 | 0.1008 | 0.3215 | 6.78 | 297,086.40 | -63.79 | -46.02 | -82.62 | -52.99 | 96.41 | 57.53 | -632.90 | -2,081.54 | 1.74 | -- | 0.4557 | -- | -- | 18.29 | -50.50 | -- | 21.35 | -- |
Data as of Jun 06 2024. Currency figures normalised to BrightGene Bio-Medical Technology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
11.11%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Wanjia Asset Management Co., Ltd.as of 31 Dec 2023 | 11.43m | 2.79% |
| HuaAn Fund Management Co., Ltd.as of 31 Dec 2023 | 8.31m | 2.03% |
| China Merchants Fund Management Co., Ltd.as of 31 Dec 2023 | 7.14m | 1.74% |
| Hui'an Fund Management Co. Ltd.as of 30 Sep 2023 | 4.52m | 1.10% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2023 | 3.62m | 0.88% |
| Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 3.31m | 0.81% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 31 Dec 2023 | 2.64m | 0.64% |
| Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 1.75m | 0.43% |
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 1.59m | 0.39% |
| The Vanguard Group, Inc.as of 09 May 2024 | 1.24m | 0.30% |
More ▼
Data from 31 Dec 2023 - 30 May 2024Source: FactSet Research Systems Inc.
